Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mattia Pandolfo

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Msystems|September 7, 2022
MetaPhage: an Automated Pipeline for Analyzing, Annotating, and Classifying Bacteriophages in Metagenomics Sequencing DataMattia Pandolfo, Andrea Telatin, Gioele Lazzari, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|January 25, 2026
Author's Reply: "Comment on ``Impact of oral butyrate on clinical and biochemical parameters in IBD: A randomized placebo-controlled study targeting gut microbiota''Sonia Facchin, Matteo Calgaro, Mattia Pandolfo, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|January 25, 2026
Author's Reply: "Reconsidering the clinical implications of oral butyrate supplementation in inflammatory bowel disease"Sonia Facchin, Matteo Calgaro, Mattia Pandolfo, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|January 22, 2026
Author's Reply: "Oral Butyrate in IBD: From enterotype stratification to a multi-omic and long-term clinical dialogue"Sonia Facchin, Matteo Calgaro, Mattia Pandolfo, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|January 25, 2026
Author's reply: Comment on "impact of oral butyrate on clinical and biochemical parameters in IBD"Sonia Facchin, Matteo Calgaro, Mattia Pandolfo, et al.
Alimentary Pharmacology & Therapeutics|July 26, 2022
Editorial: non-invasive testing for EoE-does microbiome testing hold the key? Authors' replySonia Facchin, Matteo Calgaro, Mattia Pandolfo, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|December 7, 2025
Impact of oral butyrate on clinical and biochemical parameters in IBD: A randomized placebo-controlled study targeting gut microbiotaSonia Facchin, Matteo Calgaro, Mattia Pandolfo, et al.
Alimentary Pharmacology & Therapeutics|June 18, 2022
Salivary microbiota composition may discriminate between patients with eosinophilic oesophagitis (EoE) and non-EoE subjectsSonia Facchin, Matteo Calgaro, Mattia Pandolfo, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Msystems|September 7, 2022
MetaPhage: an Automated Pipeline for Analyzing, Annotating, and Classifying Bacteriophages in Metagenomics Sequencing DataMattia Pandolfo, Andrea Telatin, Gioele Lazzari, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|January 25, 2026
Author's Reply: "Comment on ``Impact of oral butyrate on clinical and biochemical parameters in IBD: A randomized placebo-controlled study targeting gut microbiota''Sonia Facchin, Matteo Calgaro, Mattia Pandolfo, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|January 25, 2026
Author's Reply: "Reconsidering the clinical implications of oral butyrate supplementation in inflammatory bowel disease"Sonia Facchin, Matteo Calgaro, Mattia Pandolfo, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|January 22, 2026
Author's Reply: "Oral Butyrate in IBD: From enterotype stratification to a multi-omic and long-term clinical dialogue"Sonia Facchin, Matteo Calgaro, Mattia Pandolfo, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|January 25, 2026
Author's reply: Comment on "impact of oral butyrate on clinical and biochemical parameters in IBD"Sonia Facchin, Matteo Calgaro, Mattia Pandolfo, et al.
Alimentary Pharmacology & Therapeutics|July 26, 2022
Editorial: non-invasive testing for EoE-does microbiome testing hold the key? Authors' replySonia Facchin, Matteo Calgaro, Mattia Pandolfo, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|December 7, 2025
Impact of oral butyrate on clinical and biochemical parameters in IBD: A randomized placebo-controlled study targeting gut microbiotaSonia Facchin, Matteo Calgaro, Mattia Pandolfo, et al.
Alimentary Pharmacology & Therapeutics|June 18, 2022
Salivary microbiota composition may discriminate between patients with eosinophilic oesophagitis (EoE) and non-EoE subjectsSonia Facchin, Matteo Calgaro, Mattia Pandolfo, et al.
Pageof 1